Chief Executive Officer
James has 20 years’ experience in the capital markets, from the early days of his career on FNZC's (now Jarden) trading desk, to his appointment as CEO in 2017. In previous roles as FNZC Head of Securities, Head of Institutional Equities and Head of Sales and Trading, James built strong relationships with corporate and institutional clients across Australasia.
James has been involved in all Jarden's equity capital transactions for more than a decade, from IPOs to secondary sell downs, mixed ownership models and bespoke capital solutions.
His team has led capital raising efforts for some of New Zealand’s most well-known companies across a range of sectors: Mighty River, Genesis Energy, Oceania Healthcare, Z Energy, Auckland International Airport and Pacific Edge Biotech. He also led the IPO process that facilitated the growth of Kiwi success stories like Xero and Synlait Milk.
Following the global financial crisis, James and his team led a number of high profile recapitalisations, finding innovative structures that enabled prominent New Zealand companies like Nuplex and Pyne Gould Corporation (now Heartland Bank) to lay the foundations for ongoing success.
James is a Director of Jarden Group Limited. He is a member of the steering committee for Capital Markets 2029, and the investment committee for Cystic Fibrosis New Zealand. He has a Bachelor of Commerce (Economics) from the Victoria University of Wellington.